These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 11858635)

  • 1. Beware of q2!
    Golbraikh A; Tropsha A
    J Mol Graph Model; 2002 Jan; 20(4):269-76. PubMed ID: 11858635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational selection of training and test sets for the development of validated QSAR models.
    Golbraikh A; Shen M; Xiao Z; Xiao YD; Lee KH; Tropsha A
    J Comput Aided Mol Des; 2003; 17(2-4):241-53. PubMed ID: 13677490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR modeling using chirality descriptors derived from molecular topology.
    Golbraikh A; Tropsha A
    J Chem Inf Comput Sci; 2003; 43(1):144-54. PubMed ID: 12546547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents. 213. Modeling of epipodophyllotoxin derivatives using variable selection k nearest neighbor QSAR method.
    Xiao Z; Xiao YD; Feng J; Golbraikh A; Tropsha A; Lee KH
    J Med Chem; 2002 May; 45(11):2294-309. PubMed ID: 12014968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
    Oloff S; Mailman RB; Tropsha A
    J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beware of External Validation! - A Comparative Study of Several Validation Techniques used in QSAR Modelling.
    Majumdar S; Basak SC
    Curr Comput Aided Drug Des; 2018; 14(4):284-291. PubMed ID: 29701159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-chiral atom, atom-type, and total non-stochastic and stochastic molecular linear indices and their applications to central chirality codification.
    Marrero-Ponce Y; Castillo-Garit JA
    J Comput Aided Mol Des; 2005 Jun; 19(6):369-83. PubMed ID: 16231198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus kNN QSAR: a versatile method for predicting the estrogenic activity of organic compounds in silico. A comparative study with five estrogen receptors and a large, diverse set of ligands.
    Asikainen AH; Ruuskanen J; Tuppurainen KA
    Environ Sci Technol; 2004 Dec; 38(24):6724-9. PubMed ID: 15669333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on the definition of the Q2 parameter for QSAR validation.
    Consonni V; Ballabio D; Todeschini R
    J Chem Inf Model; 2009 Jul; 49(7):1669-78. PubMed ID: 19527034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new strategy to improve the predictive ability of the local lazy regression and its application to the QSAR study of melanin-concentrating hormone receptor 1 antagonists.
    Li J; Li S; Lei B; Liu H; Yao X; Liu M; Gramatica P
    J Comput Chem; 2010 Apr; 31(5):973-85. PubMed ID: 19670228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.
    Golbraikh A; Tropsha A
    Mol Divers; 2002; 5(4):231-43. PubMed ID: 12549674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
    Xiao Z; Varma S; Xiao YD; Tropsha A
    J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors.
    Kovatcheva A; Golbraikh A; Oloff S; Feng J; Zheng W; Tropsha A
    SAR QSAR Environ Res; 2005; 16(1-2):93-102. PubMed ID: 15844445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does rational selection of training and test sets improve the outcome of QSAR modeling?
    Martin TM; Harten P; Young DM; Muratov EN; Golbraikh A; Zhu H; Tropsha A
    J Chem Inf Model; 2012 Oct; 52(10):2570-8. PubMed ID: 23030316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.
    Medina-Franco JL; Golbraikh A; Oloff S; Castillo R; Tropsha A
    J Comput Aided Mol Des; 2005 Apr; 19(4):229-42. PubMed ID: 16163450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel variable selection quantitative structure--property relationship approach based on the k-nearest-neighbor principle.
    Zheng W; Tropsha A
    J Chem Inf Comput Sci; 2000 Jan; 40(1):185-94. PubMed ID: 10661566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.